Skip to main content
Year archive

MESOBLAST LTD — 2023 filings

All 127 regulatory filings released by MESOBLAST LTD (MESO) in 2023, sourced directly from the official regulator.

127 Filings
2023 Period
2023 filings (127)
Filing Released Lang
Notification of cessation of securities - MSB 4 pages 23.8KB
Regulatory Filings
2023-12-27 English
Appendix 2A 20 pages 492.7KB
Regulatory Filings
2023-12-27 English
Appendix 3Ys- J Swedish,B Burns,J Bell,P Krause,P Facchina 12 pages 428.6KB
Regulatory Filings
2023-12-27 English
Update on Institutional Placement and Entitlement Offer 2 pages 147.5KB
Regulatory Filings
2023-12-27 English
F-6 POS
Regulatory Filings
2023-12-22 English
F-6 POS
Regulatory Filings
2023-12-22 English
F-6 POS
Regulatory Filings
2023-12-21 English
Institutional Placement Cleansing Notice 1 page 245
Regulatory Filings
2023-12-11 English
Change of Director's Interest Notice - Silviu Itescu 2 pages 224.4KB
Regulatory Filings
2023-12-11 English
Appendix 2A 21 pages 522.9KB
Regulatory Filings
2023-12-10 English
Information For Retail Shareholders 90 pages 4.0MB
Regulatory Filings
2023-12-07 English
Mesoblast Completes Institutional Allocation 3 pages 213.8KB
Regulatory Filings
2023-12-04 English
MSB Launches Entitlement Offer and Placement 5 pages 323.4KB
Regulatory Filings
2023-12-03 English
Entitlement Offer and Placement Investor Presentation 53 pages 3.1MB
Regulatory Filings
2023-12-03 English
Appendix 3B Entitlement Offer and Placement 55 pages 1.1MB
Regulatory Filings
2023-12-03 English
Entitlement Offer Cleansing Notice 2 pages 183.8KB
Regulatory Filings
2023-12-03 English
Trading Halt 2 pages 230.8KB
Regulatory Filings
2023-11-30 English
6-K
Foreign Filer Report
2023-11-29 English
Amended Constitution 52 pages 1.0MB
Regulatory Filings
2023-11-28 English
Mesoblast Chairman Message to 2023 AGM 3 pages 191.8KB
Regulatory Filings
2023-11-27 English
CEO Presentation to 2023 Annual General Meeting 37 pages 2.4MB
Regulatory Filings
2023-11-27 English
Results of Meeting 3 pages 191.5KB
Regulatory Filings
2023-11-27 English
MSB Files for FDA Designations in Congenital Heart Disease 3 pages 202.9KB
Regulatory Filings
2023-11-26 English
6-K
Foreign Filer Report
2023-11-23 English
Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial 3 pages 186.2KB
Regulatory Filings
2023-11-21 English
Mesoblast Corporate Presentation 30 pages 2.1MB
Regulatory Filings
2023-11-14 English
6-K
Foreign Filer Report
2023-10-31 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 485.0KB
Regulatory Filings
2023-10-30 English
6-K
Foreign Filer Report
2023-10-30 English
Appendix 4G and Corporate Governance Statement 22 pages 589.8KB
Regulatory Filings
2023-10-29 English
Notice of Annual General Meeting and Proxy Form 30 pages 650.7KB
Regulatory Filings
2023-10-29 English
Annual Report to Shareholders 256 pages 4.7MB
Regulatory Filings
2023-10-29 English
6-K
Foreign Filer Report
2023-10-18 English
Notification regarding unquoted securities - MSB 6 pages 28.5KB
Regulatory Filings
2023-10-15 English
Notification of cessation of securities - MSB 4 pages 24.4KB
Regulatory Filings
2023-10-15 English
6-K
Foreign Filer Report
2023-10-03 English
Final Director's Interest Notice 2 pages 314.1KB
Regulatory Filings
2023-09-28 English
6-K
Foreign Filer Report
2023-09-26 English
Jane Bell Appointed Chair of Audit and Risk Committee 2 pages 144.3KB
Regulatory Filings
2023-09-25 English
6-K
Foreign Filer Report
2023-09-25 English
Mesoblast Type A Meeting with FDA 3 pages 196.2KB
Regulatory Filings
2023-09-20 English
MESOBLAST LIMITED
Major Shareholding Notification
2023-09-06 English
AMENDMENT NO. 1 TO SCHEDULE 13G
Major Shareholding Notification
2023-09-06 English
6-K
Foreign Filer Report
2023-08-31 English
20-F
Annual Report FY 2023
2023-08-31 English
Preliminary Final Report including Appendix 4E 255 pages 3.5MB
Regulatory Filings
2023-08-30 English
Annual Financial Results Presentation 28 pages 1.8MB
Regulatory Filings
2023-08-30 English
MSB Annual Financial Results and Operational Update 7 pages 560.7KB
Regulatory Filings
2023-08-30 English
Change in substantial holding 6 pages 1.0MB
Regulatory Filings
2023-08-28 English
Mesoblast 2023 Full Year Financial Results Webcast 1
Regulatory Filings
2023-08-28 English
Ceasing to be a substantial holder 4 pages 397.6KB
Regulatory Filings
2023-08-10 English
Change in substantial holding 5 pages 490.8KB
Regulatory Filings
2023-08-09 English
Ceasing to be a substantial holder 4 pages 393.1KB
Regulatory Filings
2023-08-09 English
Change in substantial holding 6 pages 495.3KB
Regulatory Filings
2023-08-08 English
Change in substantial holding 4 pages 475.9KB
Regulatory Filings
2023-08-08 English
6-K
Foreign Filer Report
2023-08-04 English
Update on BLA for Graft Versus Host Disease 3 pages 196.5KB
Regulatory Filings
2023-08-03 English
Change in substantial holding 9 pages 577.5KB
Regulatory Filings
2023-08-02 English
Trading Halt 2 pages 208.0KB
Regulatory Filings
2023-08-01 English
6-K
Foreign Filer Report
2023-08-01 English
F-6EF
Regulatory Filings
2023-07-31 English
Change in substantial holding 8 pages 554.7KB
Regulatory Filings
2023-07-31 English
6-K
Foreign Filer Report
2023-07-31 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 488.6KB
Regulatory Filings
2023-07-30 English
6-K
Foreign Filer Report
2023-07-12 English
Appendix 3G, Appendix 3H and Appendix 3Ys 26 pages 767.4KB
Regulatory Filings
2023-07-06 English
6-K
Foreign Filer Report
2023-06-13 English
Change of Director's Interest Notice 2 pages 286.2KB
Regulatory Filings
2023-06-12 English
6-K
Foreign Filer Report
2023-06-06 English
Mesoblast Director Appointed to Strategic Advisory Role 2 pages 172.6KB
Regulatory Filings
2023-06-04 English
Regulatory Filings 2023
Regulatory Filings
2023-05-30 English
PROSPECTUS
Prospectus
2023-05-26 English
6-K
Foreign Filer Report
2023-05-26 English
6-K
Foreign Filer Report
2023-05-26 English
Third Quarter Financial Results on Form 6-K 102 pages 751.4KB
Regulatory Filings
2023-05-25 English
Third Quarter Results Presentation 34 pages 2.1MB
Regulatory Filings
2023-05-25 English
MSB Reports Q3 Financial Results and Operational Highlights 8 pages 583.7KB
Regulatory Filings
2023-05-25 English
Regulatory Filings 2023
Regulatory Filings
2023-05-24 English
Regulatory Filings 2023
Regulatory Filings
2023-05-24 English
Mesoblast Third Quarter Financial Results Webcast 1
Regulatory Filings
2023-05-23 English
REGISTRATION STATEMENT
Regulatory Filings
2023-05-18 English
SCHEDULE 13G
Major Shareholding Notification
2023-05-10 English
6-K
Foreign Filer Report
2023-05-03 English
Change in substantial holding 7 pages 432.0KB
Regulatory Filings
2023-05-02 English
Becoming a substantial holder 2 pages 895.6KB
Regulatory Filings
2023-05-02 English
Cleansing Notice 1 page 234.9KB
Regulatory Filings
2023-04-30 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 392.7KB
Regulatory Filings
2023-04-27 English
Application for quotation of securities - MSB 5 pages 26.0KB
Regulatory Filings
2023-04-27 English
6-K
Foreign Filer Report
2023-04-27 English
Mesoblast Completes Private Placement 2 pages 166.9KB
Regulatory Filings
2023-04-25 English
Proposed issue of securities - MSB 5 pages 27.3KB
Regulatory Filings
2023-04-25 English
Reinstatement to Official Quotation 1 page 89.4KB
Regulatory Filings
2023-04-25 English
Voluntary Suspension 2 pages 289.5KB
Regulatory Filings
2023-04-23 English
Pause in Trading 1 page 111.0KB
Regulatory Filings
2023-04-19 English
Trading Halt 2 pages 289.9KB
Regulatory Filings
2023-04-19 English
PROSPECTUS
Prospectus
2023-04-04 English
Regulatory Filings 2023
Regulatory Filings
2023-04-04 English
Regulatory Filings 2023
Regulatory Filings
2023-03-30 English
Regulatory Filings 2023
Regulatory Filings
2023-03-28 English
REGISTRATION STATEMENT
Regulatory Filings
2023-03-24 English
6-K
Foreign Filer Report
2023-03-23 English
FDA Schedules GvHD Pre-License Manufacturing Inspection 3 pages 195.1KB
Regulatory Filings
2023-03-21 English
6-K
Foreign Filer Report
2023-03-16 English
Appendix 3G and Appendix 3H 22 pages 432.9KB
Regulatory Filings
2023-03-14 English
6-K
Foreign Filer Report
2023-03-08 English
Pause in Trading 1 page 109.5KB
Regulatory Filings
2023-03-07 English
FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L 4 pages 189.9KB
Regulatory Filings
2023-03-07 English
Prospectus for Warrants Related to Oaktree Facility 46 pages 528.6KB
Regulatory Filings
2023-03-02 English
6-K
Foreign Filer Report
2023-02-28 English
6-K
Foreign Filer Report
2023-02-27 English
Half Yearly Report and Accounts 110 pages 1.6MB
Regulatory Filings
2023-02-27 English
Second Quarter Results Presentation 29 pages 1.6MB
Regulatory Filings
2023-02-27 English
MSB Q2 Financial Results and Operational Highlights 9 pages 420.9KB
Regulatory Filings
2023-02-27 English
DREAM HF Trial Published in JACC 4 pages 235.9KB
Regulatory Filings
2023-02-27 English
Mesoblast Second Quarter Financial Results Webcast 1
Regulatory Filings
2023-02-26 English
6-K
Foreign Filer Report
2023-02-21 English
Remestemcel Clinical and Potency Studies Presented at Tandem 3 pages 174.0KB
Regulatory Filings
2023-02-16 English
6-K
Foreign Filer Report
2023-02-14 English
FDA Grants RMAT Designation for Rexlemestrocel-L in CLBP 3 pages 184.6KB
Regulatory Filings
2023-02-08 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-02-01 English
Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD 4 pages 192.3KB
Regulatory Filings
2023-01-31 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 395.6KB
Regulatory Filings
2023-01-30 English
MESOBLAST LIMITED
Major Shareholding Notification
2023-01-20 English
6-K
Foreign Filer Report
2023-01-18 English
Appendix 3G, Appendix 3H and Appendix 3Ys 25 pages 593.4KB
Regulatory Filings
2023-01-15 English
Biotech Showcase 2023 Presentation in San Francisco 28 pages 1.8MB
Regulatory Filings
2023-01-09 English
Regulatory Filings 2023
Regulatory Filings
2023-01-03 English